Dechert LLP is advising the selling shareholders on the proposed sale of STAT-Dx, a privately owned Spanish molecular diagnostics company, to QIAGEN N.V QIAGEN N.V. (NYSE:…
Qiagen’s $191 Million acquisition of STAT-Dx
Dechert LLP is advising the selling shareholders on the proposed sale of STAT-Dx, a privately owned Spanish molecular diagnostics company, to QIAGEN N.V QIAGEN N.V. (NYSE:…